RGC

NASDAQ 已收盘

Regencell Bioscience Holdings

4.36 USD
▼-0.33-7.04%
盘后 4.80 +10.09%
2026-11-19
市值
$2.07B
市盈率
—
EPS
-0.02
股息率
—
52 周区间
4.29 – 69.00
成交量
100.82K
Beta
1.71
目标价
—
52W 低 4.2952W 高 69.00
价格走势

公司简介

Regencell Bioscience Holdings Limited focuses on the research, development, and commercialization of Traditional Chinese Medicine (TCM) in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, TCM brain theory, primarily for attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.